Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a -19.538% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
[a] Cc1cc(C2=CC(=O)C[C@H](c3ccc4c(c3)OCO4)C2)ccc1F
[b] Cc1cccn2c(CNCC3OCCc4ccccc43)c(C(=O)N3CCCCC3)nc12
Answer: b. Cc1cccn2c(CNCC3OCCc4ccccc43)c(C(=O)N3CCCCC3)nc12
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1cccn2c(CNCC3OCCc4ccccc43)c(C(=O)N3CCCCC3)nc12
Cc1cccn2c(CNCC3OCCc4ccccc43)c(C(=O)N3CCCCC3)nc12
[3-[(3,4-dihydro-1H-isochromen-1-ylmethylamino)methyl]-8-methylimidazo[1,2-a]pyridin-2-yl]-piperidin-1-ylmethanone